Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ... Journal of the National Comprehensive Cancer Network 19 (2), 191-226, 2021 | 531 | 2021 |
Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis R Vargas, JA Rauh-Hain, J Clemmer, RM Clark, A Goodman, ... Gynecologic oncology 133 (2), 216-220, 2014 | 204 | 2014 |
NCCN guidelines® insights: Ovarian cancer, version 3.2022: Featured updates to the NCCN guidelines DK Armstrong, RD Alvarez, FJ Backes, JN Bakkum-Gamez, L Barroilhet, ... Journal of the National Comprehensive Cancer Network 20 (9), 972-980, 2022 | 186 | 2022 |
Type 1 diabetes mellitus and pregnancy R Vargas, JT Repke, SH Ural Reviews in obstetrics and gynecology 3 (3), 92, 2010 | 112 | 2010 |
Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England … R Vargas, LM Barroilhet, K Esselen, E Diver, M Bernstein, DP Goldstein, ... The Journal of reproductive medicine 59 (5-6), 188-194, 2014 | 77 | 2014 |
Alcohol accelerates loss of muscle and impairs recovery of muscle mass resulting from disuse atrophy R Vargas, CH Lang Alcoholism: Clinical and Experimental Research 32 (1), 128-137, 2008 | 59 | 2008 |
Elevated plasma tissue inhibitor of metalloproteinase‐1 levels predict decreased survival in castration‐resistant prostate cancer patients WK Oh, R Vargas, S Jacobus, K Leitzel, MM Regan, P Hamer, K Pierce, ... Cancer 117 (3), 517-525, 2011 | 58 | 2011 |
Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer LM Chambers, EL Esakov Rhoades, R Bharti, C Braley, S Tewari, ... Cancer research 82 (24), 4654-4669, 2022 | 41 | 2022 |
Effects of electrosurgery and vaginal closure technique on postoperative vaginal cuff dehiscence J Fanning, J Kesterson, M Davies, J Green, L Penezic, R Vargas, ... JSLS: Journal of the Society of Laparoendoscopic Surgeons 17 (3), 414, 2013 | 41 | 2013 |
Mucinous adenocarcinoma of the endometrium compared with endometrioid endometrial cancer: a SEER analysis JA Rauh-Hain, RJ Vargas, J Clemmer, RM Clark, LS Bradford, ... American journal of clinical oncology 39 (1), 43-48, 2016 | 34 | 2016 |
The microbiome and gynecologic cancer: current evidence and future opportunities LM Chambers, P Bussies, R Vargas, E Esakov, S Tewari, O Reizes, ... Current oncology reports 23 (8), 92, 2021 | 33 | 2021 |
Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists LM Chambers, R Vargas, CM Michener Journal of gynecologic oncology 30 (3), 2019 | 31 | 2019 |
A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology LM Chambers, AB Costales, K Crean-Tate, M Kuznicki, M Morton, ... Gynecologic Oncology 158 (3), 794-802, 2020 | 27 | 2020 |
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response R Vargas, P Gopal, GB Kuzmishin, R DeBernardo, SA Koyfman, BK Jha, ... NPJ Precision Oncology 2 (1), 14, 2018 | 26 | 2018 |
Changes in clinical presentation of postterm choriocarcinoma at the New England Trophoblastic Disease Center in recent years E Diver, T May, R Vargas, M Bernstein, D Goldstein, R Berkowitz Gynecologic Oncology 130 (3), 483-486, 2013 | 23 | 2013 |
Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer LM Chambers, M Kuznicki, M Yao, A Chichura, M Gruner, O Reizes, ... Gynecologic Oncology 159 (3), 699-705, 2020 | 21 | 2020 |
Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy LM Chambers, J Chalif, M Yao, A Chichura, M Morton, M Gruner, ... Gynecologic Oncology 162 (2), 368-374, 2021 | 19 | 2021 |
Impact of antibiotic treatment on immunotherapy response in women with recurrent gynecologic cancer LM Chambers, CM Michener, PG Rose, O Reizes, M Yao, R Vargas Gynecologic Oncology 161 (1), 211-220, 2021 | 18 | 2021 |
PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer PG Rose, M Yao, LM Chambers, H Mahdi, R DeBernardo, CM Michener, ... Anti-Cancer Drugs 32 (10), 1086-1092, 2021 | 14 | 2021 |
Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening C Carr, J Son, M Yao, A Priyadarshini, J Marquard, R Vargas, C Michener, ... Gynecologic Oncology 159 (3), 712-720, 2020 | 14 | 2020 |